Press Releases

 Filter by Provider

Psychedelic therapy has a continuity-of-care problem. People often pursue treatment outside their existing mental health care, leaving their therapists disconnected from potentially significant therapeutic experiences.

The 19(a) monthly distribution notices for Franklin Managed Municipal Income Trust (NYSE: PMM) and Franklin Municipal Opportunities Trust (NYSE: PMO) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.

LogProstyle Inc. (NYSE American: LGPS) (the “Company” or “LogProstyle”), headquartered in Minato-ku, Tokyo, Japan, today announced that it has paid the second quarterly installment of the cash dividend declared by its Board of Directors on July 13, 2026. The payment, in the amount of US$0.0115 per share represents the second installment of the previously announced cash dividend of US$0.046 per share.

There may be a Secret Sant-AI behind your presents this year. New Visa research finds 41% of Americans wouldn't tell someone that AI helped choose their gift as more shoppers quietly hand AI the job of finding gifts and tracking down deals. More than half of U.S. adults (54%) have already used AI for at least one shopping task, up from 47% last year.

Green Plains Inc. (NASDAQ: GPRE) today announced an agreement for the transfer of Clean Fuel Production Tax Credits, also known as 45Z tax credits, generated across Green Plains’ operating facilities, all of which are expected to qualify under the program.

FICO (NYSE: FICO), global analytics software leader, today announced that Fairway Home Mortgage, Movement Mortgage and Rate have enrolled in the FICO® Preferred Program and will continue to pull FICO® Scores across their mortgage lending operations.

RBC Bearings Incorporated (NYSE: RBC), a leading international manufacturer of highly engineered precision bearings, components and essential systems for the industrial, aerospace and defense markets, today reported results for the second quarter fiscal 2027.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2026 and provided an update on recent business progress.

ARCTRUST Private Capital, the capital markets division of the ARCTRUST Group of Companies, and Edison Equity Residential celebrated the groundbreaking of Serenova at Dripping Springs, a 175-residence, 55+ age-restricted community in Dripping Springs, Texas, located in the Austin metro area. The groundbreaking follows the August closing of the project’s construction loan, provided by North River Partners.

Real REMAX Group (NASDAQ: REAX), a leading technology-enabled global real estate platform, today released results from its September 2026 Agent Survey, highlighting the impact of higher mortgage rates on buyer and seller behavior and expectations for the housing market heading into 2027. The findings point to a housing market where buyers have more negotiating leverage, but higher borrowing costs continue to constrain purchasing power and transaction activity. Both the share of agents reporting buyer-favorable market conditions and those identifying affordability as the biggest challenge for buyers reached their highest levels since the survey began in January 2025.

Powerlaw Corp. (Nasdaq: PWRL) (“PWRL” or the "Fund"), a publicly traded fund offering exposure to private technology companies, today announced the sources of its monthly distribution of $0.0812 per share payable on October 30, 2026, to stockholders of record as of October 20, 2026.

Piper Sandler Companies (NYSE: PIPR) has released its most recent financial results.

Kohl’s (NYSE: KSS) is helping families make the most of their holiday budgets with thousands of deals, gifts at $5, $10, $15, and $20, Kohl’s Cash, and chances to win prizes. The retailer’s three November savings events include Black Friday Early Access, Nov. 6–8; Black Friday Week, Nov. 22–28; and Cyber Deals, Nov. 29–30.

Caffrey, an AI platform for financial regulation, today extended its research coverage to regulators in the U.K., Hong Kong, Singapore, Canada and the Cayman Islands. The platform is one of 10 startups named a 2026 FIA Innovator ahead of FIA Expo in Chicago, Nov. 2–4.

For the first time, IRA owners have a defined route to correct errors like a missed required minimum distribution. That route repairs the account. It does nothing about a balance already sitting with IRS collections.

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Anadarko Securities Litigation:

Centralized Supply Chain Services, LLC (CSCS®), together with Applebee’s® and IHOP®, have named Pacific Prime Meats and Custom Foods of America their 2026 Supplier Partners of the Year, honoring the companies for their collaboration, innovation, and commitment to supporting restaurant success across the Applebee’s and IHOP systems. The awards were presented at the Applebee’s Franchise Conference and IHOP Supplier Summit in Austin, Texas.

NEW ALBANY, Ohio, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Tuesday, November 24, 2026, at 8:30 a.m. ET. A press release detailing the company’s third quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the third quarter results will be available on the company’s website at approximately 7:30 a.m. ET.

The OVIN Report identifies commercial-to-defense adaptation, autonomous systems, testing and trusted supply chains as priorities that management considers relevant to the Company's existing operations

Parties agree in principle to pursue acquisition of 100% of Tranglo, subject to definitive documentation and agreement with Ripple Markets APAC

Move supports the company’s long-term growth strategy and goal of pursuing a listing on the Nasdaq Stock Exchange

Completed enrollment in Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis; topline results remain on track for 1H27

HOUSTON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fervo Energy (“Fervo” or the “Company”) (NASDAQ: FRVO), a global pioneer of next-generation geothermal energy, today announced that it will release third quarter 2026 financial and operational results before the market opens on Monday, November 9, 2026. The Company will host a webcast and conference call that same day at 10:00 a.m. ET (9:00 a.m. CT) to discuss the results.

New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical’s Copernicus™ program, expanding Profound’s commercial reach

Launching a new premium cookware line or refreshing seasonal kitchenware listings on Shopify and Amazon often hits an expensive operational wall. Traditional studio photography requires shipping heavy cast iron dutch ovens, staging elaborate kitchen countertops, and waiting weeks for edited proofs. When e-commerce teams turn to generative visual tools to…

CLEARWATER, Fla. - Traffic accidents involving motorcycles, pedestrians, and commercial trucks can leave injured individuals facing medical expenses, lost income, and uncertainty about their legal options. Tragos, Sartes & Tragos, a Clearwater, Florida, law firm, provides information to help individuals understand personal injury claims and the legal considerations that may follow…

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) --

CLEARWATER, Fla. - Serious accidents, suspected medical negligence, and criminal allegations can create difficult legal questions for individuals and families. Tragos, Sartes & Tragos, a Clearwater, Florida, law firm, provides information about these legal matters to help people better understand the issues involved and identify potential next steps. When a fatal…

NIAID-RNCP elects to evaluate the efficacy of Entolimod on gastrointestinal acute radiation syndrome ("GI-ARS"), after the announcement of positive safety findingsFully funded study will evaluate Entolimod's potential to improve survival rates and gastrointestinal ("GI") tissue recovery following radiation exposureTop-line results anticipated in early December, providing the next key development milestone for Valion Bio's lead biologic drug candidate and, if positive, will further support Entolimod's potential role in government preparedness for radiological and nuclear mass-casualty scenarios

104th Annual Italian American Awards Gala will Feature Mike Del Pozzo, President of PepsiCo US Beverages, Who Will Receive the Prestigious Lifetime Achievement Award at UNICO's Signature Celebration of Heritage, Service and Excellence

From skin and joint health to hydration and metabolic wellness, discover how multifunctional collagen formulas go beyond traditional beauty support.

- Agreement complements revenue from standard gene expression and DRP® services

Transaction in Own Shares

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and nine months ended September 30, 2026, provided operating and partner program progress, and updated 2026 financial guidance.

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a fourth-quarter 2026 dividend on the Company’s common shares outstanding. A quarterly dividend of ninety-one and a half cents (C$0.9150) per common share will be paid on December 30, 2026, to shareholders of record at the close of business on December 9, 2026.

Pretzel Therapeutics, Inc., a clinical-stage biotechnology company advancing a new class of medicines designed to restore mitochondrial function, improve cellular energetics and impede disease progression across a range of neurological and rare diseases, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the company’s clinical trial application for PX578, the company’s lead therapeutic candidate being developed for patients with POLG-mediated mitochondrial disorders (POLG disease), a rare, progressive genetic disorder caused by mutations in the POLG gene causing a depletion of mitochondrial DNA.

Trane Technologies (NYSE: TT), a global climate innovator, brings together engineers, innovators and industry leaders for bold conversations at the forefront of sustainable technology in Season 6 of the Healthy Spaces Podcast. Co-hosted by Trane Technologies leaders Scott Tew, Vice President and Global Head of Sustainability Strategy, and Dominique Silva, Marketing Leader for Europe, Middle East and Africa, this season explores the pivotal moment when breakthrough ideas move beyond research and begin delivering real-world impact across industries.

LCI Industries (NYSE: LCII) (“LCI”), today announced that its Board of Directors, in consultation with its outside financial and legal advisors, has unanimously determined that the unsolicited, non-binding proposal received from Monomoy Capital Partners to acquire LCI for $101 per share in cash does not constitute a superior proposal and is not reasonably likely to lead to a superior proposal.

Dominion Energy, Inc. (NYSE: D), today announced unaudited net income determined in accordance with Generally Accepted Accounting Principles (GAAP, or reported earnings) for the three months ended Sept. 30, 2026, of $1.2 billion ($1.30 per share) compared with net income of $1.0 billion ($1.16 per share) for the same period in 2025.

Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for varegacestat, an investigational, oral, once-daily gamma secretase inhibitor (GSI), for the treatment of adults with desmoid tumors. Validation confirms that the application is complete, and the EMA will initiate review under the centralized marketing authorization procedure.

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the third quarter ended September 30, 2026.

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that it will host an investor and analyst webinar on Friday, November 6, 2026, from 4:35 p.m. to 6:05 p.m. ET. The event will feature remarks on Braveheart Bio's cardiac myosin inhibitor program and the global clinical development of BHB-1893 in patients with obstructive HCM and non-obstructive HCM from Management and the following speakers:

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced two upcoming presentations, including a late-breaking presentation of 52-week extension data for BHB-1893 in obstructive HCM, at the American Heart Association (AHA) Scientific Sessions 2026, taking place November 6-9, 2026, in Chicago, IL. Following the presentations, copies of the presentation materials will be available in the Investors section of the Braveheart Bio website.

Measured and Indicated silver up 189% to 38.8 Moz (10.4 Mt at 117 g/t Ag) and Inferred silver of 120.1 Moz (21.6 Mt at 171 g/t Ag)Certain figures revised from the September 22, 2026 news release; tonnages and resource classification are unchanged(All dollar amounts expressed in US dollars unless otherwise noted)

Genworth Financial, Inc. (NYSE: GNW) today announced that Tom McInerney has notified the Board of Directors of his decision to retire as President & Chief Executive Officer and step down from Genworth’s Board of Directors, effective December 31, 2026. At that time, the Board of Directors expects to name Jerome Upton, currently Genworth’s Chief Financial Officer, as President and CEO and appoint him to Genworth’s Board of Directors. Angela Simmons, currently Chief Financial Officer of Genworth’s Closed Block, is expected to become Executive Vice President and Chief Financial Officer.

TORONTO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced that the Toronto Stock Exchange (the “TSX”) has accepted the Company's notice to launch a Normal Course Issuer Bid (the “Bid”).

Shanghai Coordination Center of World Cities Day

Organising Committee of Global Observance of World Cities Day